Cempra Pharmaceuticals Inc is categorized under Research and Development Laboratories in Chapel Hill, NC and active since 2006.
Cempra Pharmaceuticals Inc was established in 2006, and today employs 1 to 4, earning Unknown per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number by the NAICS.
If you are seeking more information, feel free to contact shingai majuru at the company’s headquarters by writing to 6340 Quadrangle Drive # 100, Chapel Hill, North Carolina NC 27517 or by phoning (919) 316-6601. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Cempra Pharmaceuticals Inc |
| Contact Person: | shingai majuru |
| Address: | 6340 Quadrangle Drive # 100, Chapel Hill, North Carolina 27517 |
| Phone Number: | (919) 316-6601 |
| Annual Revenue (USD): | Unknown |
| Founded: | 2006 |
| Location Type: | Headquarters |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Research and Development Laboratories |
| Share This Business: |
Cempra Pharmaceuticals Inc was started in 2006 to provide professional Research and Development Laboratories under the SIC code and NAICS code . Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact shingai majuru for inquiries that concern Cempra Pharmaceuticals Inc by calling the company number (919) 316-6601, as your correspondence is most welcome. Additionally, the physical location of the headquarters of Cempra Pharmaceuticals Inc can be found at the coordinates 35.9121,-78.97797 as well as the street address 6340 Quadrangle Drive # 100 in Chapel Hill, North Carolina 27517.
For its online presence, you may visit Cempra Pharmaceuticals Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.